ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,265Medicare Part D Prescriptions Filled, Including Refills

Rank: 231 out of 2652

$663K Total Retail Price of All Prescriptions

Rank: 296 out of 2652

419 Patients Receiving at Least One Drug in Part D
68% Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Illinois
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

34% of this provider’s 419 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LISINOPRIL 573 367 103 1 4
PROAIR HFA 490 201 95 2 39
HYDROCHLOROTHIAZIDE 475 269 84 3 13
SIMVASTATIN 460 338 87 4 1
AMLODIPINE BESYLATE 425 281 77 5 3
ACETAMINOPHEN-CODEINE 425 211 71 S3 5 93
HYDROCODONE-ACETAMINOPHEN 411 169 72 S3 7 8
PROMETHAZINE HCL 366 127 66 R 8 190
IBUPROFEN 356 173 60 9 70
TRIAMCINOLONE ACETONIDE 295 118 52 10 98
NAPROXEN 252 143 67 11 97
METFORMIN HCL 251 208 54 12 9
OMEPRAZOLE 249 140 44 13 7
LORAZEPAM 242 78 48 B 14 35
ENALAPRIL MALEATE 241 171 53 15 34
NIFEDIPINE ER 239 151 44 16 69
FUROSEMIDE 237 175 45 17 5
FLOVENT HFA 230 73 47 18 205
LEVOTHYROXINE SODIUM 206 162 41 19 2
RANITIDINE HCL 200 66 39 20 42
ATORVASTATIN CALCIUM 189 143 33 21 6
POTASSIUM CHLORIDE 187 126 32 22 16
TAMSULOSIN HCL 184 120 39 23 23
METOPROLOL TARTRATE 171 115 41 24 10
CLONIDINE HCL 165 43 25 25 64
ALPRAZOLAM 149 86 28 B 26 26
ATENOLOL 148 108 33 27 17
AMOXICILLIN 144 66 66 28 122
FLUTICASONE PROPIONATE 141 62 36 29 38
GABAPENTIN 133 89 33 30 18
METOPROLOL SUCCINATE 129 70 26 31 12
GLIPIZIDE 119 114* 29 32 44
TRAMADOL HCL 118 53 33 33 22
LOVASTATIN 113 52 20 34 37
CLOPIDOGREL 113 66 20 34 15
PREDNISONE 106 53 19 36 43
FAMOTIDINE* 102 74 14 37 40
TRAZODONE HCL 95 68 19 38 58
VENTOLIN HFA 80 45 22 39 184
HYDRALAZINE HCL 78 49 16 40 54
MONTELUKAST SODIUM 74 16 12 41 50
HYDROXYZINE HCL 72 <11 11 R 42 196
WARFARIN SODIUM 71 66* 13 43 11
PANTOPRAZOLE SODIUM 71 66* 13 43 20
JANUVIA 70 54 12 45 52
NEXIUM 69 <11 <11 46 46
SERTRALINE HCL 69 26 11 46 27
ALLOPURINOL 67 46 14 48 30
AMITRIPTYLINE HCL 62 34 12 R 49 96
TRIAMTERENE-HCTZ 59 54* 14 50 47
HYDROCORTISONE 59 27 11 50 233
CRESTOR 56 <11 <11 52 29
LOSARTAN POTASSIUM 55 25 12 53 14
PAROXETINE HCL 55 <11 <11 53 78
SYMBICORT 54 <11 <11 55 124
AMOX TR-POTASSIUM CLAVULANATE 54 38 42 55 116
LANTUS SOLOSTAR 53 40 16 57 75
DONEPEZIL HCL 51 51 15 58 24
DIOVAN 50 <11 <11 59 33
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.